These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10853217)

  • 21. Arginine vasopressin in vasodilatory shock.
    Fuchs FD; Filho JW
    Circulation; 2003 Nov; 108(19):e141; author reply e141. PubMed ID: 14610004
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of shock.
    De Backer D
    Acta Clin Belg; 2011; 66(6):438-42. PubMed ID: 22338308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study.
    Dünser MW; Mayr AJ; Ulmer H; Knotzer H; Sumann G; Pajk W; Friesenecker B; Hasibeder WR
    Circulation; 2003 May; 107(18):2313-9. PubMed ID: 12732600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of vasodilatory shock: defining the role of arginine vasopressin.
    Dunser MW; Wenzel V; Mayr AJ; Hasibeder WR
    Drugs; 2003; 63(3):237-56. PubMed ID: 12534330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock.
    Nygren A; Thorén A; Ricksten SE
    Acta Anaesthesiol Scand; 2009 May; 53(5):581-8. PubMed ID: 19239407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arginine vasopressin in advanced vasodilatory shock.
    De Backer D; Creteur J; Vincent JL
    Circulation; 2003 Nov; 108(19):e142; author reply e142. PubMed ID: 14610005
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
    Seguin P; Bellissant E; Le Tulzo Y; Laviolle B; Lessard Y; Thomas R; Mallédant Y
    Clin Pharmacol Ther; 2002 May; 71(5):381-8. PubMed ID: 12011824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II and Vasopressin for Vasodilatory Shock: A Critical Appraisal of Catecholamine-Sparing Strategies.
    Heavner MS; McCurdy MT; Mazzeffi MA; Galvagno SM; Tanaka KA; Chow JH
    J Intensive Care Med; 2021 Jun; 36(6):635-645. PubMed ID: 32223515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis.
    Polito A; Parisini E; Ricci Z; Picardo S; Annane D
    Intensive Care Med; 2012 Jan; 38(1):9-19. PubMed ID: 22127480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impedance cardiography for aortic balloon counterpulsation impact assessment on patients hemodynamics during acute myocardial infarction.
    Brazdzionyte J; Macas A
    Medicina (Kaunas); 2006; 42(11):904-13. PubMed ID: 17172792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors.
    Dünser MW; Mayr AJ; Tür A; Pajk W; Barbara F; Knotzer H; Ulmer H; Hasibeder WR
    Crit Care Med; 2003 May; 31(5):1394-8. PubMed ID: 12771608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
    Greif M; Zwermann L; Reithmann C; Weis M
    Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin infusion in children with catecholamine-resistant septic shock.
    Vasudevan A; Lodha R; Kabra SK
    Acta Paediatr; 2005 Mar; 94(3):380-3. PubMed ID: 16028663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adverse effects of inotropic drugs in hypertrophic cardiomyopathy].
    Pérez-Cimarra C; Font C; Gredilla E; Gilsanz F
    Rev Esp Anestesiol Reanim; 2007; 54(7):453-4. PubMed ID: 17953346
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of dopamine and norepinephrine in shock.
    De Santis V; Nencini C; Tritapepe L
    N Engl J Med; 2010 Jun; 362(24):2329; author reply 2330-1. PubMed ID: 20560160
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants.
    Meyer S; Löffler G; Polcher T; Gottschling S; Gortner L
    Acta Paediatr; 2006 Oct; 95(10):1309-12. PubMed ID: 16982509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.